SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GrOwnValve Meets Primary Safety Endpoint in First-in-Human Heart Valve Study

All five patients completed six-month follow-up without predefined prosthesis-related safety events.

Related stories